08D

Sulfamethoxazole

Created:	2011-10-13
Last modified:	2020-05-26

Find Related PDB Entry
5 entries where 08D is found as a standalone ligand

Help Find related ligands:
Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Help

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	28
Chiral Atom Count	0
Bond Count	29
Aromatic Bond Count	11

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	Sulfamethoxazole
Synonyms	4-amino-N-(5-methyl-1,2-oxazol-3-yl)benzenesulfonamide; SMX; SMZ
Systematic Name (OpenEye OEToolkits)	4-azanyl-N-(5-methyl-1,2-oxazol-3-yl)benzenesulfonamide
Formula	C₁₀ H₁₁ N₃ O₃ S
Molecular Weight	253.278
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	ACDLabs	12.01	O=S(=O)(Nc1noc(c1)C)c2ccc(N)cc2
SMILES	CACTVS	3.370	Cc1onc(N[S](=O)(=O)c2ccc(N)cc2)c1
SMILES	OpenEye OEToolkits	1.7.6	Cc1cc(no1)NS(=O)(=O)c2ccc(cc2)N
Canonical SMILES	CACTVS	3.370	Cc1onc(N[S](=O)(=O)c2ccc(N)cc2)c1
Canonical SMILES	OpenEye OEToolkits	1.7.6	Cc1cc(no1)NS(=O)(=O)c2ccc(cc2)N
InChI	InChI	1.03	InChI=1S/C10H11N3O3S/c1-7-6-10(12-16-7)13-17(14,15)9-4-2-8(11)3-5-9/h2-6H,11H2,1H3,(H,12,13)
InChIKey	InChI	1.03	JLKIGFTWXXRPMT-UHFFFAOYSA-N

Drug Info: DrugBank

DrugBank data are sourced from datasets licensed under a Creative Common's Attribution-NonCommercial 4.0 International License

DrugBank ID	DB01015
Name	Sulfamethoxazole
Groups	investigational approved
Description	Sulfamethoxazole is a bacteriostatic sulfonamide antibiotic that interferes with folic acid synthesis in susceptible bacteria.[L11830] It is generally given in combination with [trimethoprim], which inhibits a sequential step in bacterial folic acid synthesis - these agents work synergistically to block two consecutive steps in the biosynthesis of nucleic acids and proteins which are necessary for bacterial growth and division, and using them in conjunction helps to slow the development of bacterial resistance.[L11830] In this combination, sulfamethoxazole is useful for the treatment of a variety of bacterial infections, including those of the urinary, respiratory, and gastrointestinal tracts.
Synonyms	3-Sulfanilamido-5-methylisoxazole 4-Amino-N-(5-methyl-3-isoxazolyl)benzenesulfonamide Sulphamethoxazole SMX Sulfamethoxazole 3-(p-Aminophenylsulfonamido)-5-methylisoxazole Sulfametoxazol
Brand Names	Nu-cotrimox Sus 40/8mg/ml Bactrim Roche Inj Septra Septra DS sulfamethoxazole-trimethoprim (SMZ) Septra Grape Septra Pediatric Suspension Sulfamethoxazole Sulfamethox-TMP DS Roubac Tab 80/400 SULFAMETHOXAZOLE and TRIMETHOPRIM Teva-trimel DS Sulfameth/Trimeth-DS Bactrim DS Roubac Tab 160/800 Trisulfa S Suspension Sulfamethoxazole Tab 500mg Protrin Df Tab Sulfamethoxazole and Trimethoprim DS Sulfamethoxazole and Trimethoprim Tablets Trisulfa DS Tab Sulfatrim Pediatric Nu-cotrimox Tab 400/80mg Sulfamethoxazole and Trimethoprim for Injection, USP Septra DS Tablets Riva-sep DS Sulfamethoxazole and Trimethoprim Double Strength Sulfamethoxazole and Trimethoprim Injection, BP Apo Sulfamethoxazole Tab 500mg Bactrim Roche Suspension Paediatric Teva-trimel Septra Injection SULFAMETHOXAZOLE AND TRIMETHOPRIM double strength Bactrim DS Roche Tab Nu-cotrimox-DS Tab 800/160mg Bactrim Roche Tab Protrin Tab Apo-sulfatrim Oral Suspension Sulfamethoxazole and Trimethoprim Sulfatrim SulfatrimTM Pediatric Suspension Bactrim Sulfatrim DS Trisulfa Tab Sulfamethoxazole and Trimethoprim (Double Strength)
Indication	Sulfamethoxazole is indicated in combination with trimethoprim, in various formulations, for the following infections caused by bacteria with documented susceptibility: urinary tract infections, acute otitis media in pediatric patients (when clinically indicated), acute exacerbations of chronic bronchitis in adults, enteritis caused by susceptible _Shigella_, prophylaxis and treatment of _Pneumocystis jiroveci_ pneumonia, and travelers' diarrhea caused by enterotoxigenic _E. coli_.[L11830,L11863] In Canada, additional indications include the adjunctive treatment of cholera, treatment of bacillary dysentery, nocardiosis, and second-line treatment of brucellosis in combination with [gentamicin] or [rifampicin].[L11851]
Categories	Agents causing hyperkalemia Agents Causing Muscle Toxicity Amines Aniline Compounds Anti-Bacterial Agents Anti-Infective Agents Antibacterials for Systemic Use Antibiotics for Pneumocystis Pneumonia Antiinfectives for Systemic Use Antimycobacterials Benzene Derivatives Benzenesulfonamides Blood Glucose Lowering Agents BSEP/ABCB11 Inhibitors BSEP/ABCB11 Substrates Cytochrome P-450 CYP2C9 Inhibitors Cytochrome P-450 CYP2C9 Inhibitors (strength unknown) Cytochrome P-450 CYP2C9 Substrates Cytochrome P-450 CYP3A Inhibitors Cytochrome P-450 CYP3A Substrates Cytochrome P-450 CYP3A4 Inhibitors Cytochrome P-450 CYP3A4 Inhibitors (strength unknown) Cytochrome P-450 CYP3A4 Substrates Cytochrome P-450 Enzyme Inhibitors Cytochrome P-450 Substrates Drugs causing inadvertant photosensitivity Drugs for Treatment of Tuberculosis Drugs that are Mainly Renally Excreted Genito Urinary System and Sex Hormones Gynecological Antiinfectives and Antiseptics Hypoglycemia-Associated Agents Intermediate-Acting Antibacterial Sulfonamides Methemoglobinemia Associated Agents Photosensitizing Agents Potential QTc-Prolonging Agents QTc Prolonging Agents Sulfanilamides Sulfonamide Antibacterial Sulfonamides Sulfonamides and trimethoprim Sulfones Sulfur Compounds
ATC-Code	J04AM08 J01EE01 G01AE10 J01EC01
CAS number	723-46-6

Drug Targets

DrugBank data are sourced from datasets licensed under a Creative Common's Attribution-NonCommercial 4.0 International License

Name	Target Sequence	Pharmacological Action	Actions
Dihydropteroate synthase	MKLFAQGTSLDLSHPHVMGILNVTPDSFSDGGTHNSLIDAVKHANLMINA...	unknown	antagonist
Cytochrome P450 2C9	MDSLVVLVLCLSCLLLLSLWRQSSGRGKLPPGPTPLPVIGNILQIGIKDI...	unknown	substrate,inhibitor
Arylamine N-acetyltransferase 1	MDIEAYLERIGYKKSRNKLDLETLTDILQHQIRAVPFENLNIHCGDAMDL...	unknown	substrate
Arylamine N-acetyltransferase 2	MDIEAYFERIGYKNSRNKLDLETLTDILEHQIRAVPFENLNMHCGQAMEL...	unknown	substrate
Cytochrome P450 3A4	MALIPDLAMETWLLLAVSLVLLYLYGTHSHGLFKKLGIPGPTPLPFLGNI...	unknown	substrate
Albumin	MKWVTFISLLFLFSSAYSRGVFRRDAHKSEVAHRFKDLGEENFKALVLIA...	unknown	substrate
Bile salt export pump	MSDSVILRSIKKFGEENDGFESDKSYNNDKKSRLQDEKKGDGVRVGFFQL...	unknown	inhibitor
View More

Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682

Related Resource References

Resource Name	Reference
PubChem	5329
ChEMBL	CHEMBL443
ChEBI	CHEBI:9332
CCDC/CSD	SLFNMB02, SLFNMB09, SLFNMB01, GUSHAD01, SLFNMB06, SLFNMB08, SLFNMB04, SLFNMB07, SLFNMB03, QIBCIQ, QIBCEM, SLFNMB05, QIBCOW, SLFNMB12, SLFNMB11, SLFNMB13, SLFNMB15, SLFNMB17, SLFNMB18, SLFNMB14, SLFNMB16, SLFNMB19, SLFNMB20, SLFNMB21, GUSHAD06, GUSHAD18, GUSHAD22, GUSHAD15, GUSHAD09, GUSHAD03, GUSHAD20, GUSHAD04, GUSHAD10, GUSHAD16, GUSHAD17, GUSHAD19, GUSHAD13, GUSHAD11, GUSHAD08, GUSHAD14, GUSHAD21, SLFNMB10, GUSHAD12, GUSHAD02, GUSHAD05, GUSHAD07
COD	4100620, 4100621, 4508170, 1551659